David A. Gonyer
2021
In 2021, David A. Gonyer earned a total compensation of $1.6M as President and Chief Executive Officer at Evoke Pharma, a 39% increase compared to previous year.
Compensation breakdown
| Bonus | $127,050 |
|---|---|
| Option Awards | $888,723 |
| Salary | $550,000 |
| Other | $60,192 |
| Total | $1,625,965 |
Gonyer received $888.7K in option awards, accounting for 55% of the total pay in 2021.
Gonyer also received $127.1K in bonus, $550K in salary and $60.2K in other compensation.
Rankings
In 2021, David A. Gonyer's compensation ranked 6,902nd out of 12,405 executives tracked by ExecPay. In other words, Gonyer earned more than 44.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,902 out of 12,405 | 44th |
Division Manufacturing | 3,012 out of 5,494 | 45th |
Major group Chemicals And Allied Products | 1,335 out of 2,369 | 44th |
Industry group Drugs | 1,191 out of 2,090 | 43rd |
Industry Pharmaceutical Preparations | 866 out of 1,537 | 44th |
Source: SEC filing on March 15, 2022.
Gonyer's colleagues
We found two more compensation records of executives who worked with David A. Gonyer at Evoke Pharma in 2021.